EU Supply Integrity Guidelines
Check out Alira Health’s latest publication
In the document, best practices for European distribution and supply integrity management are highlighted as emerged from discussions with Alira Health’s internal experts and industry practitioners. The documents set out the key components of a successful distribution strategy at the corporate and country level and in the pre-launch phase that pharmaceutical companies should adopt for patent-protected medicines in order to increase the effectiveness and performance of European distribution.
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
7e Journée start-up innovantes du dispositif médical
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Data Intelligence for Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Event: Innovations In Wound Healing Annual Conference
Join Dr. Mitch Sanders for an exclusive poster session at this event.
Event: SAWC Fall 2021
Join Dr. Sanders at SAWC Fall in Las Vegas, NV.
Infographic: Indication Prioritization and Pre-Commercial Value Assessment
Download our infographic on Indication Prioritization and Pre-Commercial Value Assessment.
Subscribe to our newsletter for the latest news, events, and thought leadership